Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1998-03-05
1999-04-06
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514474, 514706, A61K 3170, A61K 3134, A61K 31095
Patent
active
058918531
ABSTRACT:
Compositions and methods for using the same to restore dehydroepiandrosterone (DHEA) levels in humans are described. Compositions comprising methyl sulfonyl methane and vitamin C, and additionally beta-1,3-glucan, are administered to humans to enhance DHEA levels. The compositions can be taken in various forms, such as a dried powdered mix with liquid, or as a pill, tablet, or capsule.
REFERENCES:
patent: 4518595 (1985-05-01), Coleman et al.
patent: 4559329 (1985-12-01), Herschler
patent: 4774093 (1988-09-01), Provonchee et al.
patent: 4835147 (1989-05-01), Roberts
patent: 5071878 (1991-12-01), Herschler
patent: 5077284 (1991-12-01), Loria et al.
patent: 5110810 (1992-05-01), Eich et al.
patent: 5162198 (1992-11-01), Eich et al
patent: 5609617 (1997-03-01), Shealy et al.
S. Kent, "DHEA: `Miracle` drug?", Geriatrics for the Primary Care Physician, vol. 37, No. 9, 1982, pp. 157-159.
N. Orentreich, et al., "Age Changes Sex Differences in Serum Dehydroepiandrosterone Sulfate Concentrations throughout Adulthood", The Journal of Clinical Endocrinology & Metabolism, vol. 59, No. 3, 1984, pp. 551-555.
Sulfate Concentrations throughout Adulthood , The Journal of Clinical Endocrinology & Metabolism, vol. 59, no. 3, 1984, pp. 551-555.
E. Barret-Connor, et al., "A Prospective Study of Dehydroepiandrosterone Sulfate, Mortality, and Cardiovascular Disease," The New England Journal of Medicine, vol. 315, No. 24, 1986, pp. 1519-1524.
G.B. Gordon, et al., "Reduction of Atherosclerosis by Administration of Dehydroepiandrosterone," The Journal of Clinical Investigation, vol. 82, No. 2, 1988, pp. 712-720.
W. Regelson, et al., "Hormonal Intervention: `Buffer Hormones` or `State Dependency`," vol. 518, 1988, pp. 260-273.
Y. Arad, et al., "Dehydroepiandrosterone Feeding Prevents Aortic Fatty Streak Formation and Cholersterol Accumulation in Cholesterol-fed Rabbit," Arteriosclerosis, vol. 9, No. 2, 1989, pp. 159-166.
C. Norman Shealy, DHEA: the Youth and Health Hormone, (A Keats Good Health Guide, 1996).
C. Norman Shealy, "A Review of Dehydroepiandrosterone (DHEA)," Intergrative Physiological and Behavioral Science, vol. 30, No. 4, 1995, pp. 308-313.
C. Norman Shealy, "DHEA Deficiency in Patients with Chronic Pain and Depression," J. Neurol. Orthop. Med. Surg., vol. 17, 1996, p. 6.
Randall-May Cay
Shealy C. Norman
Henley III Raymond
Shealy C. Norman
LandOfFree
Compositions and methods for enhancement of dehydroepiandrostero does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for enhancement of dehydroepiandrostero, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for enhancement of dehydroepiandrostero will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1371435